Remember the bout between Rory MacDonald and B.J. Penn that was originally scheduled for UFC 152 in Toronto, but Rory suffered a cut and it was moved back to December? Well, that bout was going to be the first in the UFC that saw the competitors undergo additional VADA drug testing. But according to Joe Ferraro of Sportsnet, there might be another bout that uses that style of testing - the UFC 154 welterweight title unification bout between Georges St. Pierre and Carlos Condit. Only they can't agree on who actually handle the testing - VADA (Voluntary Anti-Doping Agency) or USADA (US Anti-Doping Agency).
Ferraro explains in more detail:
With an upcoming title defence (or unification bout, if you will) versus interim champ Carlos (The Natural Born Killer) Condit next on the agenda, St-Pierre agreed and stated, "you can't be against virtue. If you have nothing to hide there is nothing wrong with doing additional testing such as VADA, Olympic-type testing, etc. I don't condemn the athletic commissions but you can't be against additional testing. If Carlos wants to do it, I am more than willing to go with VADA."
With one half of the yet-to-be-officially-announced title fight agreeing to additional testing, Condit's camp wasted no time in responding.
John Fuller, founder and publicist at Full Athlete Marketing, represents Condit as well as UFC lightweight champion Benson (Smooth) Henderson. When asked about the potential of his client undergoing additional testing, the answer was similar to that of GSP's camp, but with another twist.
"Carlos is obviously interested in upholding the integrity of the sport. He would be more than interested to submit to testing, but we'd prefer to do it via the U.S. Anti-Doping Agency (USADA) because we feel they are the most reputable drug testing organization in the world."
That's an interesting wrinkle. If the two can come to an agreement on what agency will handle the testing (and figure out who is going to pay for it), they would be using one of the biggest fights in recent UFC history to show off this more enhanced testing. And I like it.